Andrew D. Kaiser
Bergisch Gladbach, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma.
Journal: Frontiers in immunology
Published: March 02, 2023
Automated, scaled, transposon-based production of CAR T cells.
Journal: Journal for immunotherapy of cancer
Published: August 23, 2022
Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targeting.
Journal: Oncoimmunology
Published: June 10, 2022
Titratable Pharmacological Regulation of CAR T Cells Using Zinc Finger-Based Transcription Factors.
Journal: Cancers
Published: May 31, 2021
Adapter chimeric antigen receptor (AdCAR)-engineered NK-92 cells: an off-the-shelf cellular therapeutic for universal tumor targeting.
Journal: Oncoimmunology
Published: January 18, 2021
CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1.
Journal: Cancer immunology research
Published: January 08, 2021
Automated generation of gene-edited CAR T cells at clinical scale.
Journal: Molecular therapy. Methods & clinical development
Published: October 27, 2020
Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells.
Journal: Molecular therapy. Methods & clinical development
Published: August 20, 2020
Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenocarcinoma.
Journal: Nature communications
Published: April 21, 2020
Last Updated: 09/26/2026